AVADEL PHARMACEUTICALS - COM (AVDL)

Historical Holders from Q4 2016 to Q4 2024

Symbol
AVDL on Nasdaq
CUSIP
05337M104
Type / Class
Equity / COM
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
737K
Holdings value
$7.75M
Grand Portfolio weight change
0%
Number of holders
3
Number of sells
-2
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AVADEL PHARMACEUTICALS - COM (AVDL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 737K $7.75M -$4.37M $10.51 3
2024 Q3 1.07M $14M -$83.7M $13.12 5
2024 Q2 7.03M $98.8M -$1.04B $14.06 10
2024 Q1 67.7M $1.14B +$209M $16.89 121
2023 Q4 55.1M $778M +$14.7M $14.12 109
2023 Q3 53.8M $555M -$2.77M $10.30 95
2023 Q2 51.5M $849M +$73.3M $16.48 98
2023 Q1 48.4M $443M +$138M $9.16 88
2022 Q4 33.5M $239M +$16.2M $7.16 83
2022 Q3 31.4M $157M -$10.6M $5.01 72
2022 Q2 33.7M $82.3M -$28.5M $2.44 75
2022 Q1 35.8M $245M +$7M $6.83 76
2021 Q4 34.9M $282M +$3.98M $8.08 78
2021 Q3 32.1M $314M -$2.63M $9.80 81
2021 Q2 32.6M $219M -$1.45M $6.73 79
2021 Q1 32.6M $294M +$1.57M $9.04 77
2020 Q4 32M $214M +$3.57M $6.68 78
2020 Q3 31.5M $159M -$40.7M $5.04 76
2020 Q2 36.3M $293M +$72.7M $8.08 72
2020 Q1 26.8M $211M +$56.7M $7.94 53
2019 Q4 18.2M $138M +$2.57M $7.55 42
2019 Q3 19.4M $80.6M +$347K $4.16 39
2019 Q2 19.3M $55.8M -$531K $2.89 39
2019 Q1 19.6M $28.2M -$906K $1.44 36
2018 Q4 19.7M $50.9M -$1.39M $2.58 46
2018 Q3 20.1M $88.4M -$2.84M $4.39 60
2018 Q2 20.6M $126M -$36.2M $6.13 66
2018 Q1 25.9M $189M -$4.82M $7.29 71
2017 Q4 25.8M $211M -$16.9M $8.20 73
2017 Q3 27.1M $284M -$5.52M $10.50 77
2017 Q2 26.1M $288M +$21.6M $11.03 72
2017 Q1 26.6M $257M +$216M $9.68 67
2016 Q4 4.3M $44.7M +$44.7M $10.39 6